N (Percent %) | ||||
---|---|---|---|---|
Total number of patients = 60 | ||||
Gender | Female | 10(16.7%) | ||
Male | 50(83.3%) | |||
Smoking | Ex-smoker | 33(55.0%) | ||
Non-smoker | 9(15.0%) | |||
Smoker | 18(30.0%) | |||
No. of tumors | 2-7 | 57(95.0%) | ||
>8 | 3(5.0%) | |||
Stage | Primary CIS | 2(3.3%) | ||
T1 | 24(40.0%) | |||
Ta | 34(56.7%) | |||
Grade | High grade | 23(38.3%) | ||
Low grade | 37(61.7%) | |||
Histology | Papillary | 55(91.7%) | ||
Concomitant CIS and papillary | 3(5.0%) | |||
Primary CIS | 2(3.3%) | |||
BCG | BCG Complete | 42(70%) | ||
BCG Termination | 18(30%) | |||
BCG Termination reasons | BCG Refractory | 3(16.7%) | ||
BCG intolerance | 11(61.1%) | |||
BCG resistance | 2(11.1%) | |||
BCG sepis | 2(11.1%) | |||
Median | Maximum | Minimum | Mean | |
Age (Years) | 63 | 81 | 37 | 61.7 |
Cigarette pack-year | 60 | 150 | 10 | 55.4 |
No. of BCG installation | 18 | 18 | 3 | 15.7 |
Follow up time (Years) | 3.98 | 7.8 | 8.28 months | 4.1 |